Jacobs Levy Equity Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-6,423
Closed -$239K – 1015
2022
Q2
$239K Hold
6,423
– – ﹤0.01% 947
2022
Q1
$284K Sell
6,423
-2,056
-24% -$89.1K ﹤0.01% 929
2021
Q4
$360K Sell
8,479
-73,928
-90% -$3.11M ﹤0.01% 878
2021
Q3
$3.58M Buy
+82,407
New +$3.65M 0.02% 500
2018
Q1
– Sell
-18,810
Closed -$466K – 1004
2017
Q4
$466K Buy
+18,810
New +$519K 0.01% 767
2016
Q2
– Sell
-107,030
Closed -$2.01M – 1162
2016
Q1
$2.01M Sell
107,030
-692,870
-87% -$12.2M 0.04% 408
2015
Q4
$14.8M Buy
799,900
+84,200
+12% +$1.51M 0.29% 112
2015
Q3
$11.7M Sell
715,700
-195,230
-21% -$3.34M 0.24% 128
2015
Q2
$16.1M Sell
910,930
-87,600
-9% -$1.57M 0.31% 112
2015
Q1
$17.7M Sell
998,530
-823,958
-45% -$13M 0.3% 114
2014
Q4
$24.1M Buy
1,822,488
+458,560
+34% +$5.86M 0.41% 71
2014
Q3
$16.1M Sell
1,363,928
-4,200
-0.3% -$52.9K 0.27% 123
2014
Q2
$17.5M Buy
+1,368,128
New +$17.8M 0.29% 112
2014
Q1
– Sell
-12,230
Closed -$147K – 897
2013
Q4
$147K Buy
+12,230
New +$144K ﹤0.01% 887
2013
Q3
– Sell
-1,129,900
Closed -$10.5M – 931
2013
Q2
$10.5M Buy
+1,129,900
New +$9.58M 0.19% 161

Other funds holding BSX

Jacobs Levy Equity Management's BSX Position: Q3 2022 in Review

Jacobs Levy Equity Management sold out of Boston Scientific (BSX) in Q3 2022, closing a stake of 6,423 shares — an estimated $239K sold.

Jacobs Levy Equity Management first reported a position in BSX in Q2 2013 and held it in 15 quarters. The position peaked at $24.1M in Q4 2014. 866 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

  • Jacobs Levy Equity Management reported no remaining Boston Scientific position as of Q3 2022 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 6,423 Boston Scientific shares in Q3 2022, an estimated $239K.
  • Jacobs Levy Equity Management first reported a position in Boston Scientific in Q2 2013 and held it in 15 quarters.
  • Jacobs Levy Equity Management's Boston Scientific position peaked at $24.1M in Q4 2014.
  • 866 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2022, filed 15 Nov 2022.